Undas, Anetta <br/><br/>
Ezetimibe combined with simvastatin compared with simvastatin alone results in a greater suppression of oxidative stress and enhanced fibrinolysis in patients after acute coronary events.  [electronic resource] 

 -  Journal of cardiovascular pharmacology  Aug 2011 
 - 167-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4023 
<br/><br/><label>Standard No.: </label>10.1097/FJC.0b013e31821e8cb2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--blood<br/>Adolescent<br/>Adult<br/>Aged<br/>Azetidines--administration & dosage<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Ezetimibe<br/>Female<br/>Fibrinolysis--drug effects<br/>Humans<br/>Lipids--blood<br/>Male<br/>Middle Aged<br/>Oxidative Stress--drug effects<br/>Simvastatin--administration & dosage<br/>Treatment Outcome<br/>Young Adult